- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
DoD extends DIN-PACS contract with InformaTech
DoD extends DIN-PACS contract with InformaTechInformaTech, a provider of medical and information technology services, recently secured an extension of an existing telemedicine project and a new telemedicine contract. The company’s technical
DoD extends DIN-PACS contract with InformaTech
InformaTech, a provider of medical and information technology services, recently secured an extension of an existing telemedicine project and a new telemedicine contract. The companys technical support contract with the Defense Supply Center Philadelphia for management of the DIN-PACS project has been extended for an indefinite period of time; in addition, InformaTech was awarded a new contract by the U.S. Navy to provide acceptance testing services for the IBM PACS recently installed at the Naval Medical Center in Norfolk, VA. The Medical Services division of InformaTech, which is a wholly owned subsidiary of Dallas-based Kaneb Services, provides systems integration and open-architecture telemedicine products and services.
© 2000 Miller Freeman, Inc., a United News & Media company.
- Search again
- Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
